Factors influencing the outcome of magnetic sphincter augmentation for chronic gastroesophageal reflux disease.

about

Factors influencing the outcome of magnetic sphincter augmentation for chronic gastroesophageal reflux disease.

Item

http://www.wikidata.org/entity/Q38701022

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Factors influencing the outcom ...... stroesophageal reflux disease.

@en

type

Item

label

Factors influencing the outcom ...... stroesophageal reflux disease.

@en

prefLabel

Factors influencing the outcom ...... stroesophageal reflux disease.

@en

P1476

Factors influencing the outcom ...... astroesophageal reflux disease

@en

P2093

Alexander S Farivar

http://www.w3.org/2001/XMLSchema#string

Heather F Warren

http://www.w3.org/2001/XMLSchema#string

Lisa M Brown

http://www.w3.org/2001/XMLSchema#string

Matias Mihura

http://www.w3.org/2001/XMLSchema#string

Ralph W Aye

http://www.w3.org/2001/XMLSchema#string

P2860

Short-term outcomes using magnetic sphincter augmentation versus Nissen fundoplication for medically resistant gastroesophageal reflux disease.

Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy.

Epidemiology of gastro-oesophageal reflux disease: a systematic review

Obesity increases oesophageal acid exposure.

LINX® magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis.

Hill classification is superior to the axial length of a hiatal hernia for assessment of the mechanical anti-reflux barrier at the gastroesophageal junction.

Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease.

Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

The LINX® reflux management system: confirmed safety and efficacy now at 4 years.

Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease.

P2888

s00464-017-5696-5

P304

405-412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00464-017-5696-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brian E Louie

P577

2017-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090294640

http://www.w3.org/2001/XMLSchema#string

P698

28664433

http://www.w3.org/2001/XMLSchema#string

P921

gastroesophageal reflux disease